FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

921079011000036101: Levovist (galactose 2.498 g + palmitic acid 2.5 mg) powder for injection, 2.5 g vial (trade product unit of use)


Status: current, Defined. Date: 31-Oct 2010. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
933756011000036118 Levovist (galactose 2.498 g + palmitic acid 2.5 mg) powder for injection, 2.5 g vial (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
933757011000036115 Levovist (galactose 2.498 g + palmitic acid 2.5 mg) powder for injection, 2.5 g vial en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Levovist (galactose 2.498 g + palmitic acid 2.5 mg) powder for injection, 2.5 g vial has Australian BoSS galactose true Inferred relationship Some 1560571778
Levovist (galactose 2.498 g + palmitic acid 2.5 mg) powder for injection, 2.5 g vial has unit of use vial true Inferred relationship Some 1560571779
Levovist (galactose 2.498 g + palmitic acid 2.5 mg) powder for injection, 2.5 g vial Is a trade product unit of use true Inferred relationship Some
Levovist (galactose 2.498 g + palmitic acid 2.5 mg) powder for injection, 2.5 g vial Is a Levovist true Inferred relationship Some
Levovist (galactose 2.498 g + palmitic acid 2.5 mg) powder for injection, 2.5 g vial Is a galactose 2.498 g + palmitic acid 2.5 mg injection, 2.5 g vial true Inferred relationship Some
Levovist (galactose 2.498 g + palmitic acid 2.5 mg) powder for injection, 2.5 g vial has manufactured dose form powder for injection true Inferred relationship Some
Levovist (galactose 2.498 g + palmitic acid 2.5 mg) powder for injection, 2.5 g vial has intended active ingredient galactose true Inferred relationship Some 1560571778
Levovist (galactose 2.498 g + palmitic acid 2.5 mg) powder for injection, 2.5 g vial has intended active ingredient palmitic acid true Inferred relationship Some 1547127266
Levovist (galactose 2.498 g + palmitic acid 2.5 mg) powder for injection, 2.5 g vial has Australian BoSS palmitic acid true Inferred relationship Some 1547127266

Inbound Relationships Type Active Source Characteristic Refinability Group
Levovist (1 x 2.5 g vial, 1 x 20 mL inert diluent ampoule), 1 pack has TPUU True Levovist (galactose 2.498 g + palmitic acid 2.5 mg) powder for injection, 2.5 g vial Inferred relationship Some 1
Levovist (1 x 2.5 g vial, 1 x 20 mL inert diluent ampoule), 1 pack has TPUU True Levovist (galactose 2.498 g + palmitic acid 2.5 mg) powder for injection, 2.5 g vial Inferred relationship Some 2

Reference Sets

Trade product unit of use reference set

Back to Start